Latest KFF Health News Stories
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
The drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive.
Federal Experts’ Advice On HPV Vaccine Could Leave Adults Confused
A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. But some public health advocates worry that the advice doesn’t provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine.
Doctors Argue Plans To Remedy Surprise Medical Bills Will ‘Shred’ The Safety Net
A case of questionable logic.
Watch: What Happened To That $500K Dialysis Bill
After journalists investigate, Fresenius, one of the largest dialysis providers in the U.S., has agreed to waive a half-million-dollar bill. Sovereign Valentine, from Plains, Mont., said it’s a “huge relief.”
Estrellas del deporte popularizan terapias con células madre que no están probadas
Médicos están preocupados por el mensaje equivocado que se está enviando sobre estos tratamientos que, dicen, no están probados y realmente no aceleran los procesos de recuperación.
Drugmakers Master Rolling Out Their Own Generics To Stifle Competition
Known as “authorized generics,” in-house spinoffs of brand-name drugs quietly undermine the competition.
Superstar Athletes Popularize Unproven Stem Cell Procedures
Treatments for baseball pitcher Max Scherzer and other pros may mislead fans about costly, controversial, unapproved stem cell shots.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Infusion Treatments — Needed or Not — Can Deplete Patients’ Wallets
When it comes to physician-administered infusion drugs, doctors sometimes have a financial reason for their choice and patients often aren’t aware of cheaper options.
KHN’s ‘What The Health?’: Deciphering The Democrats’ Health Debate
Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN’s Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.
Proyecto en California combatiría acuerdos que atrasan salida al mercado de genéricos
La FTC ha estimado que los acuerdos de pago por retraso le cuestan a los consumidores y contribuyentes estadounidenses $3.5 mil millones, en costos más altos de medicamentos cada año.
California Bill Would Fight Deals That Delay Generic Drugs
As California Attorney General Xavier Becerra cracks down on pharmaceutical companies he said paid competitors to delay generic versions of their drugs, he’s also pushing for legislation that would give his department tools to catch more of them. It’s the first of its kind in the nation.
Trump Administration ‘Open For Business’ On Drug Imports From Canada
HHS secretary announces a preliminary plan Wednesday to allow Americans to import certain lower-cost drugs from Canada. Manufacturers were quick to criticize the plan, saying it does not guarantee the safety of drugs coming into the country.
Trump Administration Moves To Make Health Care Costs More Transparent
The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients’ care.
In A Messy Democratic Presidential Debate, Facts About ‘Medicare For All’ Get Tossed About
Candidates used their varying views on how to achieve universal coverage — whether through Medicare for All or more incremental steps — as a means to differentiate themselves from the field.
‘If You Like Your Plan, You Can Keep It.’ Biden’s Invokes Obama’s Troubled Claim.
The health policy landscape is very different than it was when Barack Obama made this pledge as part of his pitch for the Affordable Care Act. But the words still might be risky for Democratic presidential primary hopeful Joe Biden.
Ahora te verá la Dra. Alexa: ¿Está Amazon preparado para venir al rescate?
Amazon se ha asociado con numerosas compañías de atención médica, incluyendo varias en California, para permitir que los clientes y empleados usen Alexa para ayudarlos con la atención médica.
Creator Of Brain Exam That Trump Aced Demands New Training For Testers
Geriatricians are outraged over a new requirement to pay for training in order to administer the MoCA test, a widely used tool to screen for cognitive problems. The test’s creator said he was worried about accuracy and liability.
Doctor Alexa Will See You Now: Is Amazon Primed To Come To Your Rescue?
Amazon, along with a host of other technology companies, is working on ways to use its smart speaker devices to bring a range of health care services into your home.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
